BioArctic AB (publ)
BRCTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $0 |
| % Growth | -96.4% | -69.6% | 1,173.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 90.8% | 94.8% | 99.1% | 88.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | $1 | -$0 |
| % Margin | -18.5% | 45.7% | 83.4% | -52.8% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$0 | $0 | $1 | -$0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | $0 | $1 | -$0 |
| % Margin | -615.2% | 24.6% | 79.2% | -31.1% |
| EPS | -0.1 | 1.09 | 11.55 | -0.36 |
| % Growth | -109.2% | -90.6% | 3,308.3% | – |
| EPS Diluted | -0.1 | 1.09 | 11.53 | -0.36 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | $1 | -$0 |
| % Margin | -11.2% | 47.8% | 83.8% | -42.7% |